Jisheng Li

Dr. Jisheng Li

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 December 2022 in Biomaterials
Verified
Journal Article
Closed access
BZBowen Zhang
Bowen Zhang
GCGan Chen
Gan Chen
XWXumin Wu
Xumin Wu
YLYunxing Li
Yunxing Li
YXYao Xiao
Yao Xiao
XPXuetao Pei
Xuetao Pei

4 August 2022 in Cell Stem Cell
Verified
Journal Article
Closed access
JQJinhua Qin
Jinhua Qin
JZJian Zhang
Jian Zhang
JJJianan Jiang
Jianan Jiang
BZBowen Zhang
Bowen Zhang
JLJisheng Li
Jisheng Li
XPXuetao Pei
Xuetao Pei

23 April 2023 in Cell Proliferation
Verified
Journal Article
Open access
XWXumin Wu
Xumin Wu
BZBowen Zhang
Bowen Zhang
KCKeyi Chen
Keyi Chen
JZJiahui Zhao
Jiahui Zhao
YLYunxing Li
Yunxing Li
YLYanhua Li
Yanhua Li
Human embryonic stem cells (hESCs) have become an ideal cell source for the ex vivo generation of megakaryocyte (MK) and platelet products for clinical applications. However, an ongoing challenge is to establish scalable culture systems to maximize the yield of stem cell‐derived MKs that release platelets. We defined a specific dynamic 3D manufacturing system in a baffled‐flow manner that could remarkably facilitate megakaryopoiesis and increase the yield of platelet‐producing MKs from hESCs within a 12‐day induction period. Additionally, an increased number of >16N ploidy MKs, proplatelets, and platelets were generated from induced cells harvested on Day 12 using the specific dynamic culture method. The specific dynamic culture method significantly enhanced endothelium‐to‐haematopoietic transition and early haematopoiesis. More importantly, MK fate was significantly facilitated in a specific dynamic manner during early haematopoiesis. Mechanistically, this dynamic culture significantly enhanced mitochondrial function via the oxidative phosphorylation pathway and caused differentiation skewing of hESCs toward megakaryopoiesis. This study can aid in the automatic and scalable production of MKs from stem cells using baffled‐flow bioreactors and assist in the manufacturing of hESC‐derived MK and platelet products.

Verified
Journal Article
Open access
PDF file
JLJisheng Li
Jisheng Li
BZBowen Zhang
Bowen Zhang
YLYunqiao Li
Yunqiao Li
CLChuanli Liu
Chuanli Liu
轩唐轩 唐
轩 唐
YLYanhua Li
Yanhua Li
Serine and folate metabolism play critical roles in erythroid development in both embryonic and adult mice; however, the precise roles of these metabolic pathways in erythropoiesis and the pathophysiology of anemia remain inadequately characterized in the literature. To delineate the contributions of serine and folate metabolism to erythroid differentiation, we focused on serine hydroxymethyltransferase 2 (SHMT2), a key regulatory enzyme within these metabolic pathways. Using gene-editing techniques, we created fetal and adult mouse models with targeted deletion of Shmt2 in the hematopoietic system. Our findings demonstrated that the deletion of Shmt2 within the hematopoietic system led to the distinctive anemia phenotype in both fetal and adult mice. Detailed progression analysis of anemia revealed that Shmt2 deletion exerts stage-specific effects on the development and maturation of erythroid cells. Specifically, Shmt2 deficiency promoted erythroid differentiation in the R2 (CD71+ Ter119−) cell population residing in the bone marrow while concurrently inhibiting the proliferation and erythroid differentiation of the R3 (CD71+ Ter119+) cell population. This disruption resulted in developmental arrest at the R3 stage, significantly contributing to the anemia phenotype observed in the models. This study elucidates the critical role of Shmt2 in erythroid development within the hematopoietic system, highlighting the underlying mechanisms of erythroid developmental arrest associated with Shmt2 loss.

15 July 2026 in Science Advances
Verified
Journal Article
Open access
JQJinhua Qin
Jinhua Qin
ZHZheng Hua
Zheng Hua
XZXingxing Zhao
Xingxing Zhao
JJJianan Jiang
Jianan Jiang
JLJisheng Li
Jisheng Li
YLYanhua Li
Yanhua Li
The generation of megakaryocytes (MKs) from human somatic cells through chemical reprogramming represents a promising strategy for developing alternative platelet sources. Building on our prior chemical reprogramming protocol for converting erythroblasts to MKs, we established a robust method that successfully generated induced MKs (iMKs) from human cord blood-derived CD3+ T cells, which is a more abundant source. This method used a five-small molecule cocktail containing a reprogramming booster, AZD4205, to promote erasure of T cell identity and facilitate fate transition toward MKs. T cell-derived iMKs exhibited characteristic MK cellular and molecular signatures, demonstrating the capacity to produce proplatelets and release functional platelets. Single-cell RNA sequencing further revealed that iMKs were heterogeneous with distinct functional profiles, including cycling, immune, and thrombopoiesis-biased MKs. Our findings highlight an optimized chemical reprogramming strategy that enables efficient conversion of T cells to MKs, providing a practical and convenient approach to generating clinically relevant MKs and platelets.